Arteriovenous Fistula clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
A Comparison Study of the Experimental Human Acellular Vessel For Dialysis in End-Stage Renal Disease
open to eligible people ages 18 years and up
The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access
at UC Davis UC Irvine UCLA UCSD UCSF
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
Sorry, not currently recruiting here
The primary study objective is to evaluate the benefit of the Sirolimus eluting Collagen implant (SeCI; Sirogen), a single dose prophylactic treatment delivered intraoperatively at the time of surgical creation of an arteriovenous fistula for hemodialysis vascular access.
at UCSF
Last updated: